Sorrento Therapeutics Inc (SRNE)

[dia76ca]

I have held Sorrento less than a year and am up almost 700%. And there is a lot of Covid news to come. I like our chances with COVI-MSC. And Abivertinib looks interesting against cytokine storm. But trials take time. That's the way it is with all biotechs! We should hear soon about the Covid tests. I don't agree that Covid is going away. And I like everything I hear about the three forms(injection, DROPS and plasmid DNA) of the 2020 Mab.

Meanwhile the cancer portfolio is advancing. It alone is worth the current share price! Abivertinib has outstanding potential in 3 or 4 indications. The Mayo Clinic ADNAB technology is going after 10 indications and was an amazing aquisition. The Smartpharm technology is equally exciting. And the Dar-T trial should be announced any day. And there are a couple more Chinese and Korean partnerships advancing nicely...milestone and royalty payments are not far off.

The pain portfolio is also worth more than the current share price!SP-102 has a huge potential market and so does RTX! These are both blockbusters IMO.

The Sorrento share price is not inflated. It has been held down by organized shorting. That too will end. The Sorrento Covid, cancer and pain portfolios are great. And investments in Celularity and ImmunoBio are about to pay off. And the PSS lawsuit will soon be settled . Each one of these could net Sorrento over a billion $. I remain long and strong!

I can't find another small biotech with better triple digit potential!